GlassScriptPhysician profile
Daniel Maselli
NPI 1760877310
$8,212.98
in general payments reported to CMS, 2019-2025
8 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.79 · 2023: $6,112 · 2024: $1,736 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,375 · Food and Beverage: $960 · Travel and Lodging: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,375.00 |
| Food and Beverage | $960.19 |
| Travel and Lodging | $832.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $6,061.66 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Boston Scientific Corporation | $1,927.76 | 2024-2025 | Overstitch Endoscopic Suturing System, Overstitch Nxt Endoscopic Suturing System |
| Novo Nordisk INC | $86.80 | 2023-2024 | Wegovy, Saxenda |
| 3-D Matrix, INC. | $62.18 | 2024 | |
| Eagle Pharmaceuticals, INC. | $46.61 | 2023-2024 | |
| Lilly USA, LLC | $22.33 | 2024 | Zepbound |
| Micro-Tech Endoscopy USA, INC. | $5.64 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Maselli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.